Beginning Feb. 23, the Department of Health Care Services (DHCS) will implement a new fee-for-service reimbursement methodology for covered outpatient drugs. The methodology will reimburse the lower of the actual acquisition cost (as determined by the Centers for Medicare & Medicaid Services), the federal upper limit, the maximum allowable ingredient cost, and the pharmacy’s usual and customary charge. For more details about the changes, visit the DHCS website.
State Budget Takes a Wide Variety of Health Care-Related ActionsCHA NewsDetails
DHCS Announces New COVID-19 Uninsured Group Program and Web PortalCHA News
For CFOs, directors of managed care, patient financial services staff, admissions staffDetails
DHCS Issues Self-Audit Demand of 340B ProvidersCHA News
For CEOs, CFOs, pharmacy managers, legal counsel, compliance officersDetails